Prostate cancer, Gynecology, Internal medicine, Prostate-specific antigen and Prostate are her primary areas of study. Her Prostate cancer study combines topics in areas such as Biopsy and Urology. Her studies in Gynecology integrate themes in fields like Rectal examination, Meta-analysis, PSA Velocity, Overdiagnosis and Watchful waiting.
Her research in Internal medicine focuses on subjects like Oncology, which are connected to PCA3. Her research in Prostate-specific antigen tackles topics such as Mass screening which are related to areas like Antigen. Her Prostate research is multidisciplinary, incorporating perspectives in Logistic regression, Radiology and Cohort study.
Monique J. Roobol mostly deals with Prostate cancer, Internal medicine, Oncology, Gynecology and Biopsy. The various areas that she examines in her Prostate cancer study include Prostate, Randomized controlled trial and Urology. Her Urology research focuses on subjects like Prostatectomy, which are linked to Radiation therapy and Carcinoma.
Her biological study spans a wide range of topics, including Screen detected, Epidemiology of cancer, Disease and PCA3. Her studies deal with areas such as Stage, Cancer screening, Nephrology and Epidemiology as well as Gynecology. Her work deals with themes such as Prostate biopsy and Surgery, which intersect with Biopsy.
Her primary areas of study are Prostate cancer, Internal medicine, Oncology, Biopsy and Radiology. Her study in Prostate cancer is interdisciplinary in nature, drawing from both Prostate and Randomized controlled trial. Her work on Rectal examination as part of general Prostate study is frequently linked to Health index, therefore connecting diverse disciplines of science.
All of her Internal medicine and Cohort, Prostate cancer screening, Cancer, Prostate cancer mortality and Nomogram investigations are sub-components of the entire Internal medicine study. Monique J. Roobol combines subjects such as Risk stratification and Medical physics with her study of Biopsy. Her research in Radiology intersects with topics in Multiparametric Magnetic Resonance Imaging, PI-RADS, Meta-analysis and Targeted biopsy.
Prostate cancer, Biopsy, Prostate, Radiology and Internal medicine are her primary areas of study. Prostatectomy is the focus of her Prostate cancer research. The concepts of her Biopsy study are interwoven with issues in PI-RADS, Prostate biopsy, Prostate-specific antigen, Overdiagnosis and Receiver operating characteristic.
Her Prostate research is multidisciplinary, incorporating perspectives in Grading, Medical physics and Medical imaging. Her research integrates issues of Multiparametric Magnetic Resonance Imaging, False positive paradox, Multivariate statistics and Meta-analysis in her study of Radiology. Her study looks at the relationship between Internal medicine and topics such as Oncology, which overlap with Incidence and Psa screening.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.
Ivo G. Schoots;Monique J. Roobol;Daan Nieboer;Chris H. Bangma.
European Urology (2015)
Re: Infectious complications and hospital admissions after prostate biopsy in a European randomized trial.
Stacy Loeb;Suzanne van den Heuvel;Xiaoye Zhu;Chris H. Bangma.
The Journal of Urology (2012)
Anxiety and distress during active surveillance for early prostate cancer.
Roderick C. N. van den Bergh;Marie‐Louise Essink‐Bot;Marie‐Louise Essink‐Bot;Monique J. Roobol;Tineke Wolters.
Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes.
Prasanna Sooriakumaran;Tommy Nyberg;Olof Akre;Leif Haendler.
A Decade of Active Surveillance in the PRIAS Study : an Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment
Leonard P. Bokhorst;Riccardo Valdagni;Antti Rannikko;Yoshiyuki Kakehi.
European Urology (2016)
Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication
Andrew Vickers;Angel Cronin;Monique Roobol;Caroline Savage.
Journal of Clinical Oncology (2010)
Performance of the Prostate Cancer Antigen 3 (PCA3) Gene and Prostate-Specific Antigen in Prescreened Men: Exploring the Value of PCA3 for a First-line Diagnostic Test
Monique J. Roobol;Fritz H. Schröder;Pim van Leeuwen;Tineke Wolters.
European Urology (2010)
Active Surveillance for Prostate Cancers Detected in Three Subsequent Rounds of a Screening Trial: Characteristics, PSA Doubling Times, and Outcome
Stijn Roemeling;Monique J. Roobol;Stijn H. de Vries;Tineke Wolters.
European Urology (2007)
Early Detection of Prostate Cancer in 2007: Part 1: PSA and PSA Kinetics
Fritz H. Schröder;H. Ballentine Carter;Tineke Wolters;Roderick C.N. van den Bergh.
European Urology (2008)
The story of the European Randomized Study of Screening for Prostate Cancer
F.H. Schröder;L.J. Denis;M. Roobol.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: